{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:51:51Z","timestamp":1790779911251,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1124\/mol.104.009266","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T00:34:32Z","timestamp":1113525272000},"page":"20-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Molecular Determinants for the Interaction of the Valvulopathic Anorexigen Norfenfluramine with the 5-HT2B Receptor"],"prefix":"10.1016","volume":"68","author":[{"given":"Vincent","family":"Setola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Dukat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Glennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan L","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.104.009266_bib1","doi-asserted-by":"crossref","first-page":"34614","DOI":"10.1074\/jbc.M404673200","article-title":"Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected G\u03b1q-coupled protein receptors","volume":"279","author":"Bhatnagar","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.104.009266_bib2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/pro.5560020509","article-title":"Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues","volume":"2","author":"Bigler","year":"1993","journal-title":"Protein Sci"},{"key":"#cr-split#-10.1124\/mol.104.009266_bib3.1","unstructured":"Branch CL, Johnson CN Stemp G (2002) inventors"},{"key":"#cr-split#-10.1124\/mol.104.009266_bib3.2","unstructured":"SmithKline Beecham, assignee. Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors. U.S. patent 6,465,485. 2002 Oct 15."},{"key":"10.1124\/mol.104.009266_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/hrt.70.6.537","article-title":"Primary pulmonary hypertension and fenfluramine use","volume":"70","author":"Brenot","year":"1993","journal-title":"Br Heart J"},{"key":"10.1124\/mol.104.009266_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0026-895X(25)13653-5","article-title":"A single point mutation (Phe340\u2192Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors","volume":"43","author":"Choudhary","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.104.009266_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"#cr-split#-10.1124\/mol.104.009266_bib7.1","unstructured":"Dengel F, Ehrmann O, Friedrich L Zimmermann F (1975) inventors"},{"key":"#cr-split#-10.1124\/mol.104.009266_bib7.2","unstructured":"Knoll A.G. Chemische Fabriken, assignee. Theophylline derivatives. U.S. patent 3,926,995. 1975 Dec 16."},{"key":"10.1124\/mol.104.009266_bib8","doi-asserted-by":"crossref","first-page":"14118","DOI":"10.1021\/bi960545z","article-title":"Thermodynamics of ligand binding to acyl-coenzyme A binding protein studied by titration calorimetry","volume":"35","author":"Faergeman","year":"1996","journal-title":"Biochemistry"},{"key":"10.1124\/mol.104.009266_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.104.009266_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.2042-7158.1982.tb04755.x","article-title":"Effect of norfenfluramine and two structural analogues on brain 5-hydroxyindoles and serum prolactin in rats","volume":"34","author":"Fuller","year":"1982","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1124\/mol.104.009266_bib11","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci"},{"key":"10.1124\/mol.104.009266_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1126\/science.1072327","article-title":"Activation of central melanocortin pathways by fenfluramine","volume":"297","author":"Heisler","year":"2002","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.104.009266_bib13","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/pro.5560041004","article-title":"Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18 and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B","volume":"4","author":"Huang","year":"1995","journal-title":"Protein Sci"},{"key":"10.1124\/mol.104.009266_bib14","doi-asserted-by":"crossref","first-page":"18353","DOI":"10.1074\/jbc.273.29.18353","article-title":"Thermodynamics and molecular simulation analysis of hydrophobic substrate recognition by aminotransferases","volume":"273","author":"Kawaguchi","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.104.009266_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(24)39293-6","article-title":"A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a \u201csalt-bridge disruption\u201d mechanism","volume":"293","author":"Kristiansen","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.104.009266_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/1568026023393796","article-title":"Molecular biology of serotonin receptors structure and function at the molecular level","volume":"2","author":"Kroeze","year":"2002","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/mol.104.009266_bib17","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1242\/jcs.00902","article-title":"G-protein-coupled receptors at a glance","volume":"116","author":"Kroeze","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1124\/mol.104.009266_bib18","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm764","article-title":"Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension","volume":"8","author":"Launay","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/mol.104.009266_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1006\/jmbi.1996.0781","article-title":"Binding of amino acid side-chains to S1 cavities of serine proteinases","volume":"266","author":"Lu","year":"1997","journal-title":"J Mol Biol"},{"key":"10.1124\/mol.104.009266_bib20","doi-asserted-by":"crossref","first-page":"17170","DOI":"10.1074\/jbc.M200195200","article-title":"The serotonin binding site of human and murine 5-HT2B receptors: molecular modeling and site-directed mutagenesis","volume":"277","author":"Manivet","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.104.009266_bib21","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/BF00442554","article-title":"Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia","volume":"99","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1124\/mol.104.009266_bib22","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0040-4020(95)00968-X","article-title":"1,4-Conjugate addition of the Reformatsky reagent to \u03b1-nitrostyrenes: a new synthesis of \u03b3-nitroesters","volume":"52","author":"Menicagli","year":"1996","journal-title":"Tetrahedron"},{"key":"10.1124\/mol.104.009266_bib23","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1021\/bi00027a006","article-title":"Energetic origins of specificity of ligand binding in an interior nonpolar cavity of T4 lysozyme","volume":"34","author":"Morton","year":"1995","journal-title":"Biochemistry"},{"key":"10.1124\/mol.104.009266_bib24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0024-3205(84)90101-2","article-title":"The ability of certain anorexic drugs to suppress food consumption depends on the nutrient composition of the test diet","volume":"35","author":"Moses","year":"1984","journal-title":"Life Sci"},{"key":"10.1124\/mol.104.009266_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00442252","article-title":"Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors","volume":"97","author":"Neill","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/mol.104.009266_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.104.009266_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/oxfordjournals.jbchem.a021561","article-title":"Paracoccus denitrificans aromatic amino acid aminotransferase: a model enzyme for the study of dual substrate recognition mechanism","volume":"121","author":"Oue","year":"1997","journal-title":"J Biochem (Tokyo)"},{"key":"10.1124\/mol.104.009266_bib28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.289.5480.739","article-title":"Crystal structure of rhodopsin: A G protein-coupled receptor","volume":"289","author":"Palczewski","year":"2000","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.104.009266_bib29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1183\/09031936.93.03050606","article-title":"Pulmonary hypertension and fenfluramine","volume":"3","author":"Pouwels","year":"1990","journal-title":"Eur Respir J"},{"key":"10.1124\/mol.104.009266_bib30","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.104.009266_bib31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.104.009266_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/mol.52.2.259","article-title":"Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors","volume":"52","author":"Roth","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.104.009266_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7258(98)00019-9","article-title":"5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function","volume":"79","author":"Roth","year":"1998","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.104.009266_bib34","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"10.1124\/mol.104.009266_bib35","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","article-title":"3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro","volume":"63","author":"Setola","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.104.009266_bib36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0026-895X(24)12458-3","article-title":"Differential modes of agonist binding to 5-hydroxytryptamine2A serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5","volume":"58","author":"Shapiro","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.104.009266_bib37","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.1074\/jbc.M111675200","article-title":"Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6","volume":"277","author":"Shapiro","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.104.009266_bib38","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1073\/pnas.2237265100","article-title":"The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice","volume":"101","author":"Shi","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.104.009266_bib39","doi-asserted-by":"crossref","first-page":"195S","DOI":"10.1378\/chest.114.3_Supplement.195S","article-title":"Primary pulmonary hypertension associated with the use of fenfluramine derivatives","volume":"114","author":"Simonneau","year":"1998","journal-title":"Chest"},{"key":"10.1124\/mol.104.009266_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1054-8807(99)00019-8","article-title":"Histologic changes in three explanted native cardiac valves following use of fenfluramines","volume":"8","author":"Steffee","year":"1999","journal-title":"Cardiovasc Pathol"},{"key":"10.1124\/mol.104.009266_bib41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1378\/chest.121.2.649","article-title":"Autopsy findings of heart and lungs in a patient with primary pulmonary hypertension associated with use of fenfluramine and phentermine","volume":"121","author":"Tomita","year":"2002","journal-title":"Chest"},{"key":"10.1124\/mol.104.009266_bib42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0028-3908(01)00063-6","article-title":"Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors","volume":"41","author":"Vickers","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.104.009266_bib43","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/clpt.1992.71","article-title":"Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2405137X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2405137X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.104.009266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:02:45Z","timestamp":1739966565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X2405137X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0026895X2405137X"],"URL":"https:\/\/doi.org\/10.1124\/mol.104.009266","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Determinants for the Interaction of the Valvulopathic Anorexigen Norfenfluramine with the 5-HT2B Receptor","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.104.009266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}